[{"address1": "Bellevue Centre", "address2": "Suite 300 235 -15th Street", "city": "West Vancouver", "state": "BC", "zip": "V7T 2X1", "country": "Canada", "phone": "604 921 1810", "fax": "604 921 1898", "website": "https://briacell.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the\nclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. William V. Williams FCPA, M.D.", "age": 70, "title": "CEO, President & Director", "yearBorn": 1955, "fiscalYear": 2025, "totalPay": 711724, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A.", "age": 52, "title": "CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2025, "totalPay": 535361, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Giuseppe  Del Priore M.D., M.P.H.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2025, "totalPay": 493048, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.095, "open": 4.08, "dayLow": 4.02, "dayHigh": 4.2095, "regularMarketPreviousClose": 4.095, "regularMarketOpen": 4.08, "regularMarketDayLow": 4.02, "regularMarketDayHigh": 4.2095, "payoutRatio": 0.0, "beta": 2.03, "forwardPE": -10.435898, "volume": 171394, "regularMarketVolume": 171394, "averageVolume": 421181, "averageVolume10days": 201460, "averageDailyVolume10Day": 201460, "bid": 3.01, "ask": 5.19, "bidSize": 2, "askSize": 2, "marketCap": 25342124, "fiftyTwoWeekLow": 4.01, "fiftyTwoWeekHigh": 98.2, "allTimeHigh": 1563.518, "allTimeLow": 3.5, "fiftyDayAverage": 7.1134, "twoHundredDayAverage": 14.67, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3136032, "profitMargins": 0.0, "floatShares": 1650961, "sharesOutstanding": 6211436, "sharesShort": 142140, "sharesShortPriorMonth": 281381, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0229, "heldPercentInsiders": 0.0060799997, "heldPercentInstitutions": 0.01049, "shortRatio": 0.14, "shortPercentOfFloat": 0.0229, "impliedSharesOutstanding": 6226566, "bookValue": 5.296, "priceToBook": 0.76850456, "lastFiscalYearEnd": 1753920000, "nextFiscalYearEnd": 1785456000, "mostRecentQuarter": 1761868800, "netIncomeToCommon": -28707256, "trailingEps": -33.87, "forwardEps": -0.39, "lastSplitFactor": "1:10", "lastSplitDate": 1756080000, "enterpriseToEbitda": 0.104, "52WeekChange": -0.9194499, "SandP52WeekChange": 0.11471915, "quoteType": "EQUITY", "currentPrice": 4.07, "recommendationKey": "none", "totalCash": 10175972, "totalCashPerShare": 5.402, "ebitda": -30268288, "totalDebt": 0, "quickRatio": 3.42, "currentRatio": 3.42, "returnOnAssets": -1.61642, "returnOnEquity": -4.44067, "freeCashflow": -18512680, "operatingCashflow": -28920240, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1331731800000, "postMarketChangePercent": -0.9828, "postMarketPrice": 4.03, "postMarketChange": -0.03999996, "regularMarketChange": -0.0249996, "regularMarketDayRange": "4.02 - 4.2095", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 421181, "fiftyTwoWeekLowChange": 0.059999943, "fiftyTwoWeekLowChangePercent": 0.014962578, "fiftyTwoWeekRange": "4.01 - 98.2", "fiftyTwoWeekHighChange": -94.13, "fiftyTwoWeekHighChangePercent": -0.95855397, "fiftyTwoWeekChangePercent": -91.94499, "dividendDate": 1577923200, "earningsTimestampStart": 1749758400, "earningsTimestampEnd": 1750104000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -33.87, "epsForward": -0.39, "marketState": "CLOSED", "fiftyDayAverageChange": -3.0433998, "fiftyDayAverageChangePercent": -0.42784038, "twoHundredDayAverageChange": -10.6, "twoHundredDayAverageChangePercent": -0.7225631, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-24", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1771028742, "regularMarketTime": 1771016402, "shortName": "BriaCell Therapeutics Corp.", "longName": "BriaCell Therapeutics Corp.", "exchange": "NCM", "messageBoardId": "finmb_262266102", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.610491, "regularMarketPrice": 4.07, "displayName": "BriaCell Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]